The natriuretic peptide system includes three known peptides: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). They contribute to the regulation of cardiovascular homeostasis through diuretic, natriuretic, and vasodilatory properties. Among them, ANP has received particular attention because of its effects on blood pressure regulation and cardiac function. Although the potential for its therapeutic application in the treatment of hypertension and heart failure has been evaluated in several experimental and clinical investigations, no pharmacological approach directly targeted at modulation of ANP levels has ever reached the stage of being incorporated into clinical practice. Recently, ANP has also received attention as being a possible cardiovascular risk factor, particularly in the context of hypertension, stroke, obesity, and metabolic syndrome. Abnormalities in either peptide levels or peptide structure are thought to underlie its implied role in mediating cardiovascular diseases. Meanwhile, BNP has emerged as a relevant marker of left ventricular (LV) dysfunction and as a useful predictor of future outcome in patients with heart failure. This review deals with the major relevant findings related to the cardiovascular and metabolic effects of natriuretic peptides, to their potential therapeutic use, and to their role in mediating cardiovascular diseases.

Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases / Rubattu, Speranza Donatella; Sciarretta, Sebastiano; V., Valenti; R., Stanzione; Volpe, Massimo. - In: AMERICAN JOURNAL OF HYPERTENSION. - ISSN 0895-7061. - STAMPA. - 21:7(2008), pp. 733-741. [10.1038/ajh.2008.174]

Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases

RUBATTU, Speranza Donatella;SCIARRETTA, SEBASTIANO;V. Valenti;VOLPE, Massimo
2008

Abstract

The natriuretic peptide system includes three known peptides: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP). They contribute to the regulation of cardiovascular homeostasis through diuretic, natriuretic, and vasodilatory properties. Among them, ANP has received particular attention because of its effects on blood pressure regulation and cardiac function. Although the potential for its therapeutic application in the treatment of hypertension and heart failure has been evaluated in several experimental and clinical investigations, no pharmacological approach directly targeted at modulation of ANP levels has ever reached the stage of being incorporated into clinical practice. Recently, ANP has also received attention as being a possible cardiovascular risk factor, particularly in the context of hypertension, stroke, obesity, and metabolic syndrome. Abnormalities in either peptide levels or peptide structure are thought to underlie its implied role in mediating cardiovascular diseases. Meanwhile, BNP has emerged as a relevant marker of left ventricular (LV) dysfunction and as a useful predictor of future outcome in patients with heart failure. This review deals with the major relevant findings related to the cardiovascular and metabolic effects of natriuretic peptides, to their potential therapeutic use, and to their role in mediating cardiovascular diseases.
2008
01 Pubblicazione su rivista::01a Articolo in rivista
Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases / Rubattu, Speranza Donatella; Sciarretta, Sebastiano; V., Valenti; R., Stanzione; Volpe, Massimo. - In: AMERICAN JOURNAL OF HYPERTENSION. - ISSN 0895-7061. - STAMPA. - 21:7(2008), pp. 733-741. [10.1038/ajh.2008.174]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/229768
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 56
  • Scopus 168
  • ???jsp.display-item.citation.isi??? 152
social impact